Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Hutchison Chi-Med JV Gains Rights to Distribute Six TCM Drugs

publication date: Jun 2, 2014
Hutchison Chi-Med said its China drug distribution JV, Shanghai Hutchison Pharma, has been granted rights to distribute six prescription TCM drugs in China. The drugs, which have annual sales of $7 million, are made by Shanghai Traditional Chinese Medicine, Chi-Med’s partner in the JV. According to Chi-Med, the six-drug package is part of a restructuring of the drug distribution JV, which does not change its equity structure, but allows an “expansion of its business scope.” Chi-Med did not elaborate. More details....

Stock Symbol: (AIM: HCM)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital